A new trading day began on Monday, with Zenas Biopharma Inc (NASDAQ: ZBIO) stock price down -51.86% from the previous day of trading, before settling in for the closing price of $34.5. ZBIO’s price has ranged from $5.83 to $44.60 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 65.60%. With a float of $21.93 million, this company’s outstanding shares have now reached $42.21 million.
Zenas Biopharma Inc (ZBIO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Zenas Biopharma Inc is 59.14%, while institutional ownership is 31.11%. The most recent insider transaction that took place on Oct 09 ’25, was worth 1,200,002. In this transaction Director of this company bought 63,158 shares at a rate of $19.00, taking the stock ownership to the 1,173,395 shares. Before that another transaction happened on Oct 09 ’25, when Company’s 10% Owner bought 126,315 for $19.00, making the entire transaction worth $2,399,985. This insider now owns 1,917,895 shares in total.
Zenas Biopharma Inc (ZBIO) Latest Financial update
Zenas Biopharma Inc (NASDAQ: ZBIO) Trading Performance Indicators
Here are Zenas Biopharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 59.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.53, a number that is poised to hit -1.00 in the next quarter and is forecasted to reach -4.45 in one year’s time.
Technical Analysis of Zenas Biopharma Inc (ZBIO)
The latest stats from [Zenas Biopharma Inc, ZBIO] show that its last 5-days average volume of 1.84 million was inferior to 4.17 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 10.80%.
During the past 100 days, Zenas Biopharma Inc’s (ZBIO) raw stochastic average was set at 10.00%, which indicates a significant increase from 10.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.90 in the past 14 days, which was higher than the 2.55 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.26, while its 200-day Moving Average is $19.34. Now, the first resistance to watch is $18.24. This is followed by the second major resistance level at $19.87. The third major resistance level sits at $22.24. If the price goes on to break the first support level at $14.24, it is likely to go to the next support level at $11.87. The third support level lies at $10.24 if the price breaches the second support level.
Zenas Biopharma Inc (NASDAQ: ZBIO) Key Stats
With a market capitalization of 891.61 million, the company has a total of 53,679K Shares Outstanding. Currently, annual sales are 5,000 K while annual income is -156,990 K. The company’s previous quarter sales were 0 K while its latest quarter income was -52,220 K.
